874 related articles for article (PubMed ID: 8864731)
1. Combined chemotherapy and radiotherapy versus surgery and postoperative radiotherapy for advanced hypopharyngeal cancer.
Zelefsky MJ; Kraus DH; Pfister DG; Raben A; Shah JP; Strong EW; Spiro RH; Bosl GJ; Harrison LB
Head Neck; 1996; 18(5):405-11. PubMed ID: 8864731
[TBL] [Abstract][Full Text] [Related]
2. Treatment results and prognostic factors in locally advanced hypopharyngeal cancer.
Lee MS; Ho HC; Hsiao SH; Hwang JH; Lee CC; Hung SK
Acta Otolaryngol; 2008 Jan; 128(1):103-9. PubMed ID: 17851955
[TBL] [Abstract][Full Text] [Related]
3. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
[TBL] [Abstract][Full Text] [Related]
4. Concurrent chemoradiotherapy with cisplatin and fluorouracil for locally advanced hypopharyngeal carcinoma.
Yoon MS; Chung WK; Ahn SJ; Nam TK; Nah BS; Song JY; Lim SC; Lee JK
Acta Otolaryngol; 2008 May; 128(5):590-6. PubMed ID: 18421617
[TBL] [Abstract][Full Text] [Related]
5. [Induction chemotherapy and larynx preservation: is such practice useful?].
Sarini J; Bocciolini C; Fournier C; Penel N; Kara A; Van JT; Lefebvre JL
Bull Cancer; 2002 Apr; 89(4):411-7. PubMed ID: 12016041
[TBL] [Abstract][Full Text] [Related]
6. Induction chemotherapy with cisplatin and 5-fluorouracil followed by chemoradiotherapy or radiotherapy alone in the treatment of locoregionally advanced resectable cancers of the larynx and hypopharynx: results of single-center study of 45 patients.
Altundag O; Gullu I; Altundag K; Yalcin S; Ozyar E; Cengiz M; Akyol F; Yucel T; Hosal S; Sozeri B
Head Neck; 2005 Jan; 27(1):15-21. PubMed ID: 15515158
[TBL] [Abstract][Full Text] [Related]
7. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
[TBL] [Abstract][Full Text] [Related]
8. Chemoradiotherapy laryngeal preservation for advanced hypopharyngeal cancer.
Tai SK; Yang MH; Wang LW; Tsai TL; Chu PY; Wang YF; Huang JL; Chang SY
Jpn J Clin Oncol; 2008 Aug; 38(8):521-7. PubMed ID: 18697758
[TBL] [Abstract][Full Text] [Related]
9. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
[TBL] [Abstract][Full Text] [Related]
10. Intensive chemoradiotherapy as a primary treatment for organ preservation in patients with advanced cancer of the head and neck: efficacy, toxic effects, and limitations.
Hanna E; Alexiou M; Morgan J; Badley J; Maddox AM; Penagaricano J; Fan CY; Breau R; Suen J
Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):861-7. PubMed ID: 15262764
[TBL] [Abstract][Full Text] [Related]
11. Squamous cell carcinoma of the hypopharynx: single-institution outcome analysis of a large cohort of patients treated with primary non-surgical approaches.
Gupta T; Chopra S; Agarwal JP; Laskar SG; D'cruz AK; Shrivastava SK; Dinshaw KA
Acta Oncol; 2009; 48(4):541-48. PubMed ID: 18979267
[TBL] [Abstract][Full Text] [Related]
12. Multi-institutional analysis of early squamous cell carcinoma of the hypopharynx treated with radical radiotherapy.
Nakamura K; Shioyama Y; Kawashima M; Saito Y; Nakamura N; Nakata K; Hareyama M; Takada T; Karasawa K; Watanabe T; Yorozu A; Tachibana H; Suzuki G; Hayabuchi N; Toba T; Yamada S
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1045-50. PubMed ID: 16682142
[TBL] [Abstract][Full Text] [Related]
13. Pilot study of postoperative reirradiation, chemotherapy, and amifostine after surgical salvage for recurrent head-and-neck cancer.
Machtay M; Rosenthal DI; Chalian AA; Lustig R; Hershock D; Miller L; Weinstein GS; Weber RS
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):72-7. PubMed ID: 15093901
[TBL] [Abstract][Full Text] [Related]
14. Disease control, survival, and functional outcome after multimodal treatment for advanced-stage tongue base cancer.
Malone JP; Stephens JA; Grecula JC; Rhoades CA; Ghaheri BA; Schuller DE
Head Neck; 2004 Jul; 26(7):561-72. PubMed ID: 15229898
[TBL] [Abstract][Full Text] [Related]
15. Does induction chemotherapy still have a role in larynx preservation strategies? The experience of Institut Catala d'Oncologia in stage III larynx carcinoma.
Majem M; Mesia R; Mañós M; Gomez J; Galiana R; Cardenal F; Juan A; Montes A; Perez FJ; Nogues J; Llluch JR
Laryngoscope; 2006 Sep; 116(9):1651-6. PubMed ID: 16954998
[TBL] [Abstract][Full Text] [Related]
16. Concurrent chemotherapy and intensity-modulated radiotherapy for locoregionally advanced laryngeal and hypopharyngeal cancers.
Lee NY; O'Meara W; Chan K; Della-Bianca C; Mechalakos JG; Zhung J; Wolden SL; Narayana A; Kraus D; Shah JP; Pfister DG
Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):459-68. PubMed ID: 17493769
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II study.
Chang PM; Chen PM; Chu PY; Wang LW; Tai SK; Tsai TL; Huang JL; Wang YF; Chang SY; Yang MH
Cancer Chemother Pharmacol; 2008 Dec; 63(1):9-17. PubMed ID: 18343925
[TBL] [Abstract][Full Text] [Related]
18. Long-term results of a phase II trial of induction chemotherapy with uracil-ftegafur (UFT), vinorelbine, and cisplatin (UFTVP) followed by radiotherapy concomitant with UFT and carboplatin (RT/UFTJ) in a primary site preservation setting for resectable locally advanced squamous cell carcinoma of larynx and hypopharynx.
Rivera F; Vega-Villegas ME; López-Brea MF; García-Castaño A; de Juan A; Collado A; Galdós P; Rubio A; del Valle A; Rama J; Sanz-Ortiz J
Laryngoscope; 2004 Jul; 114(7):1163-9. PubMed ID: 15235341
[TBL] [Abstract][Full Text] [Related]
19. Treatment outcomes for radiotherapy alone are comparable with neoadjuvant chemotherapy followed by radiotherapy in early-stage nasopharyngeal carcinoma.
Song CH; Wu HG; Heo DS; Kim KH; Sung MW; Park CI
Laryngoscope; 2008 Apr; 118(4):663-70. PubMed ID: 18216741
[TBL] [Abstract][Full Text] [Related]
20. Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up.
Psyrri A; Kwong M; DiStasio S; Lekakis L; Kassar M; Sasaki C; Wilson LD; Haffty BG; Son YH; Ross DA; Weinberger PM; Chung GG; Zelterman D; Burtness BA; Cooper DL
J Clin Oncol; 2004 Aug; 22(15):3061-9. PubMed ID: 15284256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
